|
|
||||||||
1 Division of Child Neurology, Department of Neurology, University of California at San Francisco, San Francisco, California 94143; 2 Research Center for Genetic Medicine, Children's National Medical Center, Washington, District of Columbia 20010; Departments of 3 Veterinary Biomedical Sciences, 5 Statistics, and 6 Veterinary Pathobiology, University of Missouri at Columbia, Columbia, Missouri 65211; and 4 Department of Biological Sciences, State University of New York at Buffalo, Buffalo, New York 14260-1300
Despite over 3,000 articles
published on dystrophin in the last 15 years, the reasons underlying
the progression of the human disease, differential muscle involvement,
and disparate phenotypes in different species are not
understood. The present experiment employed a screen of 12,488 mRNAs in 16-wk-old mouse mdx muscle at a time when the
skeletal muscle is avoiding severe dystrophic pathophysiology, despite
the absence of a functional dystrophin protein. A number of transcripts
whose levels differed between the mdx and human Duchenne
muscular dystrophy were noted. A fourfold decrease in myostatin mRNA in
the mdx muscle was noted. Differential upregulation of
actin-related protein 2/3 (subunit 4),
-thymosin, calponin, mast
cell chymase, and guanidinoacetate methyltransferase mRNA in the more
benign mdx was also observed. Transcripts for oxidative and
glycolytic enzymes in mdx muscle were not downregulated. These discrepancies could provide candidates for salvage pathways that
maintain skeletal muscle integrity in the absence of a functional dystrophin protein in mdx skeletal muscle.
Duchenne muscular dystrophy; dystrophin; GeneChips; microarrays
This article has been cited by other articles:
![]() |
D. G. Cerri, L. C. Rodrigues, S. R. Stowell, D. D. Araujo, M. C. Coelho, S. R. Oliveira, J. C. S. Bizario, R. D. Cummings, M. Dias-Baruffi, and M. C. R. Costa Degeneration of dystrophic or injured skeletal muscles induces high expression of Galectin-1 Glycobiology, November 1, 2008; 18(11): 842 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Castro-Gago, C. Gomez-Lado, J. Eiris-Punal, I. Carneiro, V. M. Arce, and J. Devesa Muscle Myostatin Expression in Children With Muscle Diseases J Child Neurol, January 1, 2007; 22(1): 38 - 40. [Abstract] [PDF] |
||||
![]() |
X. Shi and D. J. Garry Muscle stem cells in development, regeneration, and disease. Genes & Dev., July 1, 2006; 20(13): 1692 - 1708. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Hanft, I. N. Rybakova, J. R. Patel, J. A. Rafael-Fortney, and J. M. Ervasti Cytoplasmic {gamma}-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle PNAS, April 4, 2006; 103(14): 5385 - 5390. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fluck, C. Dapp, S. Schmutz, E. Wit, and H. Hoppeler Transcriptional profiling of tissue plasticity: role of shifts in gene expression and technical limitations J Appl Physiol, August 1, 2005; 99(2): 397 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Y. Kostrominova, D. E. Dow, R. G. Dennis, R. A. Miller, and J. A. Faulkner Comparison of gene expression of 2-mo denervated, 2-mo stimulated-denervated, and control rat skeletal muscles Physiol Genomics, July 14, 2005; 22(2): 227 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakayama, N. Nara, Y. Kawakita, Y. Takeshima, M. Arakawa, M. Katoh, S. Morita, K. Iwatsuki, K. Tanaka, S. Okamoto, et al. Cloning of cDNA Encoding a Regeneration-Associated Muscle Protease Whose Expression Is Attenuated in Cell Lines Derived from Duchenne Muscular Dystrophy Patients Am. J. Pathol., May 1, 2004; 164(5): 1773 - 1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. GROUNDS and J. TORRISI Anti-TNF{alpha} (Remicade(R)) therapy protects dystrophic skeletal muscle from necrosis FASEB J, April 1, 2004; 18(6): 676 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Porter, A. P. Merriam, P. Leahy, B. Gong, J. Feuerman, G. Cheng, and S. Khanna Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy Hum. Mol. Genet., February 1, 2004; 13(3): 257 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sanoudou, P. B. Kang, J. N. Haslett, M. Han, L. M. Kunkel, and A. H. Beggs Transcriptional profile of postmortem skeletal muscle Physiol Genomics, January 15, 2004; 16(2): 222 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. P. CHARGE and M. A. RUDNICKI Cellular and Molecular Regulation of Muscle Regeneration Physiol Rev, January 1, 2004; 84(1): 209 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Porter, A. P. Merriam, P. Leahy, B. Gong, and S. Khanna Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice Hum. Mol. Genet., August 1, 2003; 12(15): 1813 - 1821. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bey, N. Akunuri, P. Zhao, E. P. Hoffman, D. G. Hamilton, and M. T. Hamilton Patterns of global gene expression in rat skeletal muscle during unloading and low-intensity ambulatory activity Physiol Genomics, April 16, 2003; 13(2): 157 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Haslett, D. Sanoudou, A. T. Kho, R. R. Bennett, S. A. Greenberg, I. S. Kohane, A. H. Beggs, and L. M. Kunkel Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle PNAS, November 12, 2002; 99(23): 15000 - 15005. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |